Genzyme Says Agreement Reached With Icahn

Biotechnology company Genzyme (GENZ) and billionaire investor Carl Icahn have reached a settlement in their proxy fight, the company said on Wednesday – Reuters
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.